These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4958797)

  • 41. Initial treatment of tuberculosis with streptomycin and isoniazid combined with either aminosalyl or rifampicin.
    Engbaek HC; Larsen SO; Rasmussen KN; Vergmann B
    Scand J Respir Dis; 1973; 54(2):83-91. PubMed ID: 4122479
    [No Abstract]   [Full Text] [Related]  

  • 42. [Use of 4 antibacterial preparations in the treatment of destructive tuberculosis of the lungs].
    Volkon VM; Shrentsel' OA
    Probl Tuberk; 1973; 51(6):28-31. PubMed ID: 4202910
    [No Abstract]   [Full Text] [Related]  

  • 43. [Primary drug resistance of Mycobacterium tuberculosis in Kazakhstan].
    Krivtsova AE; Blagodarnyĭ IaA
    Probl Tuberk; 1974; (8):70-3. PubMed ID: 4277905
    [No Abstract]   [Full Text] [Related]  

  • 44. Pulmonary tuberculosis in the elderly.
    Keers RY
    Practitioner; 1969 Dec; 203(218):760-6. PubMed ID: 5356390
    [No Abstract]   [Full Text] [Related]  

  • 45. A continuing survey of primary drug resistance in tuberculosis, 1961 to 1968. A U.S. Public Health Service cooperative study.
    Doster B; Caras GJ; Snider DE
    Am Rev Respir Dis; 1976 Apr; 113(4):419-25. PubMed ID: 817629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Undiagnosed tuberculosis in a general hospital.
    Ashba JK; Boyce JM
    Chest; 1972 May; 61(5):447-51. PubMed ID: 4625794
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G; Petitjean R; Schranz J; Scherrer B
    Rev Tuberc Pneumol (Paris); 1970; 34(3):439-53. PubMed ID: 5515514
    [No Abstract]   [Full Text] [Related]  

  • 48. Isoniazid-resistant tuberculous superinfection.
    Greenberg HB
    J Am Geriatr Soc; 1970 May; 18(5):370-7. PubMed ID: 4985581
    [No Abstract]   [Full Text] [Related]  

  • 49. Sputum excretion of tubercle bacilli as early criterion in the evaluation of the therapeutic effectiveness of antituberculous drugs, illustrated by its use in a controlled trial of single-drug regimens.
    Schütz I; Bartmann K
    Antibiot Chemother; 1970; 16():490-500. PubMed ID: 4943581
    [No Abstract]   [Full Text] [Related]  

  • 50. Corticosteroids in pulmonary tuberculosis. 3. Indications.
    Johnson JR; Turk TL; MacDonald FM
    Am Rev Respir Dis; 1967 Jul; 96(1):62-73. PubMed ID: 5338901
    [No Abstract]   [Full Text] [Related]  

  • 51. [Results of the study "Intermittent therapy of tuberculosis within therapeutic health centers"].
    Cavić L; Kaleta J; Sazdanić D; Krstić M
    Nar Zdrav; 1972; 28(7):230-5. PubMed ID: 4633209
    [No Abstract]   [Full Text] [Related]  

  • 52. Tuberculous meningitis due to primary drug-resistant Mycobacterium tuberculosis hominis.
    Bonforte RJ; Karpas CM; Gribetz I; Shanzer S
    Pediatrics; 1968 Dec; 42(6):969-75. PubMed ID: 4973145
    [No Abstract]   [Full Text] [Related]  

  • 53. A continuing study of patients with "open negative" status at Battey State Hospital.
    Corpe RF; Blalock FA
    Am Rev Respir Dis; 1968 Dec; 98(6):954-64. PubMed ID: 4301382
    [No Abstract]   [Full Text] [Related]  

  • 54. Pulmonary cryptocococcis followed by pulmonary tuberculosis. A case report.
    Riley E; Cahan WG
    Am Rev Respir Dis; 1972 Oct; 106(4):594-9. PubMed ID: 4627831
    [No Abstract]   [Full Text] [Related]  

  • 55. [Rifamicin in the studies of the Scuola Tisiologica in Naples].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):271-92. PubMed ID: 4981409
    [No Abstract]   [Full Text] [Related]  

  • 56. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F; Centrella G; Stefanelli R
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract]   [Full Text] [Related]  

  • 57. [Inactivation of PAS and isoniazid in children with tuberculosis].
    Shenderova RI; Terterian EA
    Probl Tuberk; 1973; 51(5):67-71. PubMed ID: 4757049
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of ethionamide with isoniazid in original treatment cases of pulmonary tuberculosis. XIV. A report of the Veterans Administration--Armed Forces cooperative study.
    Schwartz WS
    Am Rev Respir Dis; 1966 May; 93(5):685-92. PubMed ID: 5936929
    [No Abstract]   [Full Text] [Related]  

  • 60. Corticosteroids in pulmonary tuberculosis. II. Importance of background factors.
    Johnson JR; Turk TL; MacDonald FM
    Am Rev Respir Dis; 1967 Jul; 96(1):43-61. PubMed ID: 5338900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.